-
ABT-263 (Navitoclax): From Mechanism to Translation
2026-09-08
A translational framework for using ABT-263 (Navitoclax) to connect Bcl-2 family dependency, mitochondrial priming, apoptosis assays, and cancer-model strategy.
-
Faropenem sodium: Reliable Assay Workflows
2026-09-08
This scenario-driven guide shows how Faropenem sodium (SKU C8712) can be incorporated into antimicrobial, co-culture, and cell-based viability workflows without confusing bacterial inhibition with mammalian cytotoxicity. It covers formulation, controls, dose-response design, interpretation, storage, and practical vendor-selection criteria.
-
Cytoskeleton-Dependent Autophagy Under Mechanical Stress
2026-09-07
Liu et al. show that the cytoskeleton is not merely associated with mechanical stress-induced autophagy: microfilaments are required for the principal change in autophagosome abundance, while microtubules provide auxiliary support. Their combination of compression, cytoskeletal polymerization perturbation, fluorescence imaging, and western blotting provides a mechanistic framework for studying force-to-autophagy signaling.
-
Thapsigargin B6614 for Reliable Cell Assays
2026-09-07
This scenario-driven guide explains how Thapsigargin (SKU B6614) can improve calcium signaling, endoplasmic reticulum stress, and apoptosis assay design. It connects product-specific formulation data with practical controls, dose selection, and interpretation strategies for reproducible laboratory workflows.
-
Fludarabine: From DNA Stress to Immune Visibility
2026-09-05
Fludarabine is more than a conventional DNA synthesis inhibitor. Its defined intracellular activation, replication-stress biology, and established oncology research use make it a useful perturbation for connecting tumor-cell death with immune recognition. This article examines how Fludarabine can support leukemia and multiple myeloma research while offering a disciplined framework for testing chemotherapy-enhanced neoantigen presentation and adoptive T cell therapy.
-
Fludarabine: A DNA Synthesis Inhibitor for Translation
2026-09-04
Fludarabine is more than a cytotoxic test article: it is a mechanistically defined DNA synthesis inhibitor that can connect replication stress, cell-cycle control, apoptosis, and translational assay strategy. This thought-leadership guide shows how to use Fludarabine in leukemia and multiple myeloma research while interpreting its relevance to genotype-informed oncology programs.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Assay Design
2026-09-04
EZ Cap Cy5 Firefly Luciferase mRNA combines Cy5-based delivery tracking with Firefly luciferase expression to separate uptake from productive translation. This article presents a decision framework for interpreting dual-reporter data, optimizing mRNA delivery and transfection, and translating formulation insights into more rigorous assays.
-
Renal Blood Flow and K+ Channels in Septic Rats
2026-09-03
This study separated ex vivo renal vascular reactivity from whole-animal renal blood-flow responses in a cecal ligation and puncture model of sepsis. Its key implication is that blocking ATP-sensitive or calcium-activated potassium channels may appear neutral alone but worsen catecholamine-associated renal hypoperfusion in septic animals.
-
7-dehydro Cholesterol as a Sterol-State Readout
2026-09-03
7-dehydro Cholesterol is more than a cholesterol precursor: it is a measurable junction between DHCR7 activity, vitamin D3 formation, photobiology, and redox stress. This guide presents an assay-centered framework for interpreting the sterol across biochemical, cellular, skin, and antiviral research.
-
Norovirus Co-opts NINJ1 for Selective Secretion
2026-09-02
Song et al. show that murine norovirus exploits the membrane-rupture factor NINJ1 to release NS1 through a caspase-3-dependent unconventional pathway. The study links viral immune evasion to regulated cell death machinery and provides a framework for separating selective viral protein secretion from bulk DAMP release.
-
Difloxacin HCl: A Framework for Better Assays
2026-09-02
Difloxacin HCl is a quinolone antimicrobial antibiotic suited to both antimicrobial susceptibility testing and multidrug resistance reversal research. This article presents a causality-focused assay framework and explains what a mitotic checkpoint study teaches researchers about interpreting molecular and phenotypic endpoints.
-
MALAT1 Levels, TDP-43 Binding, and Cell Viability
2026-09-01
The reference study shows that MALAT1 abundance is not merely correlated with TDP-43 biology: changing MALAT1 levels alters cell viability and redistributes TDP-43 binding across mRNA transcripts. Its contrasting effects in baseline and MPP+-challenged cells highlight a context-dependent RNA regulatory network relevant to neuronal survival and neurodegeneration research.
-
TCEP Hydrochloride for Capture-and-Release Assays
2026-09-01
TCEP hydrochloride brings controlled, odorless disulfide reduction to protein preparation, proteomics, and emerging capture-and-release assay workflows. This practical guide translates a high-sensitivity lateral flow strategy into testable reduction, release, cleanup, and troubleshooting steps while distinguishing published findings from recommended starting conditions.
-
SM-102 LNP Workflow for mRNA Delivery
2026-08-31
SM-102 provides a practical ionizable-lipid starting point for building and benchmarking lipid nanoparticles in mRNA delivery. This workflow combines formulation controls, assay selection, machine-learning insights, and troubleshooting so researchers can distinguish material, process, and biological sources of performance variation.
-
MOP-1 Lipid Advances Safer mRNA-LNP Vaccines
2026-08-31
The reference study introduces MOP-1, a glutarimide-derived ionizable lipid designed to improve mRNA lipid nanoparticle delivery while limiting inflammatory toxicity. In an influenza vaccine model, MOP-1-LNPs combined efficient delivery, strong antibody and CD8+ T-cell responses, favorable tolerability, 90% survival after lethal viral challenge, and near-complete viral clearance.